MOLECULAR CELL BIOLOGY OF AMYLOID PRECURSOR PROTEIN
MOLECULAR CELL BIOLOGY OF AMYLOID PRECURSOR PROTEIN
批准号:
3121187
负责人:
WILLIAM L KLEIN
金额:
$9.57万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1991
资助国家:
美国
项目状态:
已结题
起止时间:
1991-05-01 至 1994-04-30
关键词:
Alzheimer's disease aluminum amyloid proteins antibody axon calcium cell adhesion cell adhesion molecules cell death cell membrane cytoskeleton dendrites electron microscopy glucose growth cones heat stimulus hypoxia laboratory rabbit molecular biology neurogenesis neurons oxidation physiologic stressor protein purification protein structure protein structure function receptor stress stress proteins tissue /cell culture transmission electron microscopy
中文摘要
这项工作的长期目标与细胞的分子机制有关。
死于阿尔茨海默病(AD)。它的当务之急是研究
淀粉样前体蛋白的分子细胞生物学。这个
原位APP的细胞构筑特性及其功能作用
影响其表达的因素基本上是未知的。建议数
旨在解决这些差距,此外,还将有助于建立
阿尔茨海默病神经发病机制实验研究的新模型
目的1-表征APP在细胞和细胞上的结构生物学
细胞外表面,重点是对APP可能
成为细胞黏附分子。而APP的蜂窝功能是
未知,基于序列分析的一个主要假设是,这是
蛋白质是一种细胞黏附分子。为了直接检验这一假设,
并在原位表征APP分子的结构生物学,
我们最近开发了一种整装EM-免疫金方法
研究APP在培养的人神经细胞系中的表达。基于我们的
试点研究,我们建议(1)验证和扩展表征
APP形式与粘附性微纤维之间的关系可在
细胞和细胞外表面,采用整体传动
SHSY5Y人神经母细胞瘤的电子显微镜-免疫金方案
细胞培养。(2)用范式评价APP的粘合作用
测试与粘连相关的功能,如轴突延伸和生长
锥体运动性(3)以提供假定APP的初始特征
受体,使用基于粘附性的分离方案
应用程序。
目的#2-评估细胞应激因素对
应用程序表达式。众所周知,应用程序推动者具有多个控制
元素,包括与应力相关的热震序列。实验
因此已经被设计来研究APP的表达以响应
会给神经细胞带来压力的外部影响。六个因素
直接或间接与阿尔茨海默病的发病机制有关
研究(热休克、钙超载、葡萄糖退出、低氧、氧化剂
受伤和铝)。特定APP形式在细胞上的分布
和培养表面将使用成像技术进行比较;
与细胞和培养底物相关的APP表格的水平将是
用定量免疫印迹法测量。这些数据将提供必要的
对细胞应激引起显著变化的假设的检验
应用程序表达式中的异常。
英文摘要
The long-range goal of this work concerns molecular mechanisms of cell
death in Alzheimer's disease (AD). Its immediate focus is to study the
molecular cell biology of amyloid precursor protein (APP). The
cytoarchitectural nature of APP in situ, its functional role, and the
factors influencing its expression are essentially unknown. The proposed
aims address these gaps and, additionally, will help to establish a
useful new model for experimental studies of AD neuropathogenesis.
AIM #1- To characterize the structural biology of APP at cell and
extracellular surfaces, focusing on tests of the hypothesis that APP may
be a cell adhesion molecule. While the cellular function of APP is
unknown, one major hypothesis based on sequence analysis is that this
protein is a cell adhesion molecule. To test this hypothesis directly,
and to characterize the structural biology of the APP molecule in situ,
we recently have developed a whole mount EM-immunogold method for
studying APP expression in cultured human nerve cell lines. Based on our
pilot studies, we propose (1) To verify and extend characterization of
the relationship between APP forms and adhesive microfibrils found at
cell and extracellular surfaces, applying whole mount transmission
electron microscopy-immunogold protocols to SHSY5Y human neuroblastoma
cell cultures. (2) To evaluate the adhesive role of APP, using paradigms
that test adhesion-linked functions such as neurite extension and growth
cone motility (3) To provide initial characterization of a postulated APP
receptor, using isolation protocols based on the adhesive properties of
APP.
AIM #2- To evaluate the influence of cellular stress factors on
APP expression. The APP promoter is known to have multiple control
elements, including a stress-related heat shock sequence. Experiments
therefore have been designed to study APP expression in response to
external influences that can stress nerve cells. Six factors
incriminated directly or indirectly in the pathogenesis of AD will be
studied (heat shock, Ca++ overload, glucose withdrawal, hypoxia, oxidant
injury, and aluminum). The distribution of specific APP forms on cell
and culture surfaces will be compared using imaging techniques; the
levels of APP forms associated with cells and culture substratum will be
measured by quantitative immunoblots. The data will provide essential
tests of the hypothesis that cell stress causes significant changes or
anomalies in APP expression.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Physiological role of naturally-occuring amyloid beta oligomers
-
批准号:9759747
-
项目类别:
-
资助金额:$19.29万
-
财政年份:2018
-
负责人:WILLIAM L KLEIN
-
依托单位:
Development of a non-fibrillic amyloid-beta oligomer selective positron emission tomography imaging diagnostic for Alzheimer.
-
批准号:9202960
-
项目类别:
-
资助金额:$22.22万
-
财政年份:2016
-
负责人:WILLIAM L KLEIN
-
依托单位:
A novel, nanoparticle-based molecular MRI probe for early Alzheimer's diagnostics
-
批准号:8842908
-
项目类别:
-
资助金额:$18.73万
-
财政年份:2014
-
负责人:WILLIAM L KLEIN
-
依托单位:
A novel, nanoparticle-based molecular MRI probe for early Alzheimer's diagnostics
-
批准号:8683797
-
项目类别:
-
资助金额:$23.18万
-
财政年份:2014
-
负责人:WILLIAM L KLEIN
-
依托单位:
Alzheimer's Drug Discovery Using Unique Nanotechnology Platform
-
批准号:8548221
-
项目类别:
-
资助金额:$18.44万
-
财政年份:2012
-
负责人:WILLIAM L KLEIN
-
依托单位:
Alzheimer's Drug Discovery Using Unique Nanotechnology Platform
-
批准号:8446087
-
项目类别:
-
资助金额:$24.74万
-
财政年份:2012
-
负责人:WILLIAM L KLEIN
-
依托单位:
ADDLs, synapses & the molecular etiology of Alzheimer's disease
-
批准号:7615522
-
项目类别:
-
资助金额:$30.34万
-
财政年份:2007
-
负责人:WILLIAM L KLEIN
-
依托单位:
ADDLs, synapses & the molecular etiology of Alzheimer's disease
-
批准号:7184209
-
项目类别:
-
资助金额:$30.96万
-
财政年份:2007
-
负责人:WILLIAM L KLEIN
-
依托单位:
ADDLs, synapses & the molecular etiology of Alzheimer's disease
-
批准号:7470605
-
项目类别:
-
资助金额:$30.34万
-
财政年份:2007
-
负责人:WILLIAM L KLEIN
-
依托单位:
Abeta oligomers (ADDLs) in Alzheimers Disease pathology
-
批准号:6678227
-
项目类别:
-
资助金额:$33.05万
-
财政年份:2003
-
负责人:WILLIAM L KLEIN
-
依托单位:
Abeta oligomers (ADDLs) in Alzheimer's Disease pathology
-
批准号:7805554
-
项目类别:
-
资助金额:$30.65万
-
财政年份:2003
-
负责人:WILLIAM L KLEIN
-
依托单位:
Abeta oligomers (ADDLs)in Alzheimers Disease pathology
-
批准号:6931646
-
项目类别:
-
资助金额:$34.61万
-
财政年份:2003
-
负责人:WILLIAM L KLEIN
-
依托单位:
Abeta oligomers (ADDLs) in Alzheimer's Disease pathology
-
批准号:7467169
-
项目类别:
-
资助金额:$30.96万
-
财政年份:2003
-
负责人:WILLIAM L KLEIN
-
依托单位:
Abeta oligomers (ADDLs)in Alzheimers Disease pathology
-
批准号:6795925
-
项目类别:
-
资助金额:$34.62万
-
财政年份:2003
-
负责人:WILLIAM L KLEIN
-
依托单位:
Abeta oligomers (ADDLs) in Alzheimer's Disease pathology
-
批准号:7595791
-
项目类别:
-
资助金额:$30.96万
-
财政年份:2003
-
负责人:WILLIAM L KLEIN
-
依托单位:
NEUROLOGICAL DEFICITS DUE TO TOXIC A BETA OLIGOMERS
-
批准号:6233462
-
项目类别:
-
资助金额:$30.45万
-
财政年份:2001
-
负责人:WILLIAM L KLEIN
-
依托单位:
NEUROLOGICAL DEFICITS DUE TO TOXIC A BETA OLIGOMERS
-
批准号:6615732
-
项目类别:
-
资助金额:$29.23万
-
财政年份:2001
-
负责人:WILLIAM L KLEIN
-
依托单位:
NEUROLOGICAL DEFICITS DUE TO TOXIC A BETA OLIGOMERS
-
批准号:6532552
-
项目类别:
-
资助金额:$29.31万
-
财政年份:2001
-
负责人:WILLIAM L KLEIN
-
依托单位:
MORPHOGENIC SIGNAL TRANSDUCTION IN NEURONS
-
批准号:2703069
-
项目类别:
-
资助金额:$19.22万
-
财政年份:1996
-
负责人:WILLIAM L KLEIN
-
依托单位:
MORPHOGENIC SIGNAL TRANSDUCTION IN NEURONS
-
批准号:2273680
-
项目类别:
-
资助金额:$18.86万
-
财政年份:1996
-
负责人:WILLIAM L KLEIN
-
依托单位:
国内基金
海外基金
Aluminum/CFRP 混合管界面分层对渐进折叠机制影响研究
-
批准号:ZCLQN26E0501
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:沈勇
-
依托单位: